11 November 2022

AFCC 2022 Convocation and Opening Ceremony

Sukaman Lecture

  • The Heart of our Pandemic

CV Imaging in the Evaluation of LV Dysfunction

  • Assessment of LV Dysfunction in Diabetes: What are My Options?
  • LV Function Analysis Beyond EF: Echo Perspective
  • CMR Imaging in LV Dysfunction: How Useful?

Preventive Cardiology

  • What is the Effective and Safe Goal LDL for the Asians? Are We the Same as the Caucasians?
  • Future Therapies for Lipid Lowering: Injectables
  • CVD Begins in Childhood

RF/RHD and Kawasaki Disease

  • Potential CV Sequelae of KD in Adults
  • Knowledge and Practice Gaps in the RF/RHD Programs
  • Breakthroughs in RHD Tertiary Prevention

Heart Failure

  • Should We Start HF Medications in Stage B Heart Failure?
  • Worsening Heart Failure Phase in Worsening Renal Function – Is There A Roadmap?
  • Shock at a Glance: Understanding Heart Failure - Cardiogenic shock (HF-CS)

1st CPR Summit

  • The Future of CPR: from Human Intervention to Artificial Intelligence
  • Getting High on Drugs: Review and Updates on Resuscitation Medications
  • Mission Impossible: Trade Secrets for Very Difficult ACLS and Cardiac Arrest Scenarios

Asia Pacific Resuscitation Symposium: The Best Practices in Resuscitation and Resuscitation Education (Panel Discussion)

  • National Resuscitation Guidelines and National Policies on Public Access Defibrillation 
  • Changes and Challenges in CPR and CPR Training during The Pandemic and Evolution in the New Normal
  • Pediatric Resuscitation in the ASEAN Region

The Global Resuscitation Alliance (GRA): An Asian Perspective

  • Defining GRA: Steps to CPR-Readiness
  • Implementing the GRA: Best Models and Practices in the Asian Region
  • GRA: Challenges in Developing Countries

Multimodality Imaging of  LVH / Cardiomyopathy

  • Beyond Echoes of the Heart: Clinical Indications for CT and MRI
  • CMR in Hypertensive LV Hypertrophy
  • Speckle Tracking Echocardiography (Strain) for Refined Differentiation of Cardiomyopathies

Industry Symposium Lectures

  • Is there a Role for SALT2i in Heart Failure across the EF Spectrum
  • Perspectives and Emerging Evidence: Deep Dive into the Cardio-Renal Connection
  • Simplifying the Treatment Approach Across the Full Spectrum of Heart Failure
  • The Role of Edoxaban in Elderly Frail Patients

11 November 2022

12 November 2022

AFC ESC Joint Session

  • CHIP Intervention: Issues & An ASEAN Perspective
  • Sex Specific Considerations for TAVI Management in Women


  • Hypertension Beyond Numbers
  • Updates on Hypertension in the Philippines (PRESYON 4 and the 2020 Phil HPN Guidelines)
  • Revisiting Renal Denervation for the Treatment of Resistant Hypertension

Imaging in Structural Heart Disease

  • Revisiting of Guidelines for TEE Screening for Structural Heart Intervention
  • Imaging the “Forgotten Valve”: 2D and 3D Imaging of the Tricuspid Valve and Tricuspid Valve Interventions
  • Intracardiac Echocardiography (ICE) and Its Application for Interventional Cardiology. Will this Become Mainstream?

Women’s Health

  • What is the Current Status of CV Health in Women? Are They Included Already in Trials/Research for Risks Reduction in ASHD?
  • MINOCA / Broken Heart Syndrome… Why Are They Common in Women?
  • Microvascular Heart Disease in Women?


  • Sensi, Speci and Everything in Between: Accuracy and Reliability of Various Noninvasive Imaging Tools for Ischemic and Coronary Artery Disease
  • Establishing Rule-Out Protocol in Acute Chest Pain
  • Optimal Medical Therapy for Chronic Coronary Syndromes: How Far is Optimum Until Revascularization?

 Interventional Cardiology

  • PCI of the OHCA: To Do or Not To Do
  • Intravascular Imaging / Physiology: Guiding PCI to Improve Outcomes
  • Transcatheter Valvular Heart Disease Interventions: What’s In? What’s Out? What’s Next?

CV Oncology

  • Arrhythmias and QT Prolongation in Cancer Therapy: Surveillance and Management
  • Prostate Cancer and Cardiovascular Disease
  • Progressive Vasculopathy in Radiation Therapy in Cancer Patients: Surveillance, Treatment and Prevention

Vascular Conundrums

  • Approach to the Management of Ascending and Aortic Arch Conditions
  • VTE in Hypercoagulable States
  • Critical Limb Ischemia Management

CV Surgery

  • Effect of COVID on Cardiac Surgery in the Philippines
  • Minimally Invasive Cardiac Surgery (MICS) Strategies for Coronary Artery Disease
  • How we treat Mechanical complications of Acute MI focus on Post Infarct Ventricular Septal Rupture

Industry Symposium Lectures

  • Spotlight on Heart Failure: The Role of Dapagliflozin in Patients with Heart Failure Across the Range of Ejection Fraction
  • Sugar and Stroke: Protecting Patients with Atrial Fibrillation and Diabetes Mellitus
  • Defusing a Time Bomb: Managing Hypertension in the Not-So-Young
  • Sugar and Stroke: Protecting Patients with Atrial Fibrillation and Diabetes Mellitus
  • Japanese Experience with Heated Tobacco Products
  • Risk Reduction in Cardiovascular Disease in Smokers - An Evidence Based Approach
  • Brief Discussion on Vietnam Perspective

13 November 2022

AFC - APSC Joint Session

  • Stroke Prevention in Atrial Fibrillation: Asian Perspective
  • MitraClip for FMR: It is Ever Too Early?


  • Evolution of Pacing Strategies: From Heart Rate Assurance to Preservation of A-V and LV Synchrony (Physiologic pacing = His / LBB Pacing)
  • Catheter Ablation in Atrial Fibrillation Optimal Timing and Patient Selection
  • Opportunistic Screening for AF Among Patients at Risk: Use of Mobile Single Lead ECG Implantable Loop Recorders, ECG Watches

Sports Cardiology / Cardiac Rehab

  • 2021 Asia-Pacific Guidelines on Sports Participation Screening
  • Holistic Stress Management for Cardiac Rehabilitation Patients
  • Sharing of Best Practices: Remote / Tele Cardiac Rehabilitation Programs

Congenital Heart Disease

  • Impact of Risk Stratification Scoring Systems/Models' in Post Intervention/Surgery Outcome
  • Continuum of Care in Complex CHD
  • Perioperative/Procedural Management of Patients with CHD-PAH

Myocardial Diseases

  • Cardiomyopathy in COVID-19 Infection: Clinical Evaluation and Management
  • Risk of Myocarditis After COVID-19 mRNA Vaccination: An Evidence-based Review
  • Advances in the Treatment of Obstructive Hypertrophic Cardiomyopathy – Targeted Therapy with Mavacamten

Closing Ceremonies

Fellowship Night

13 November 2022

Email: secretariat@apcp2024.org
3/F Secretariat, PPS Bldg. 52 Kalayaan Avenue
Brgy. Malaya, Diliman, Quezon City, Philippines
Tel. No: (+632) 8926-6758